(firstQuint)Post-Approval Study of MelaFind.

 The primary objective of this study to test the hypothesis that, among eligible and evaluable lesions with central histological reference standard status melanoma or high-grade lesion, the relative sensitivity comparing enrolling dermatologists after MelaFind use with enrolling dermatologists if MelaFind were not available is greater than 110%.

 This represents a clinically meaningful increase in sensitivity.

 The secondary objectives of this study are to evaluate real-world use and safety and effectiveness of MelaFind in a clinical setting.

.

 Post-Approval Study of MelaFind@highlight

The purpose of this study is to collect data to describe the real-world use and safety and effectiveness of MelaFind(R) in a post-approval clinical setting.

